These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11818159)

  • 41. An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma.
    Singh A; Qin H; Fernandez I; Wei J; Lin J; Kwak LW; Roy K
    J Control Release; 2011 Oct; 155(2):184-92. PubMed ID: 21708196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chimerization of LL2, a rapidly internalizing antibody specific for B cell lymphoma.
    Leung SO; Shevitz J; Pellegrini MC; Dion AS; Shih LB; Goldenberg DM; Hansen HJ
    Hybridoma; 1994 Dec; 13(6):469-76. PubMed ID: 7737671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.
    Kaminski MS; Kitamura K; Maloney DG; Levy R
    J Immunol; 1987 Feb; 138(4):1289-96. PubMed ID: 3492546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences.
    Fredriksen AB; Bogen B
    Blood; 2007 Sep; 110(6):1797-805. PubMed ID: 17540847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Construction of a DNA vaccine against human B cell lymphoma].
    Zhang YS; Zhong KL; Yuan Y; Zhang MW; Zhang Y; Mao N
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jan; 20(1):79-82. PubMed ID: 15182628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine.
    Timmerman JM; Levy R
    J Immunol; 2000 May; 164(9):4797-803. PubMed ID: 10779787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma.
    Ruffini PA; Di Nicola M; Carlo-Stella C; Siena S; Gianni AM
    Curr Gene Ther; 2005 Oct; 5(5):511-21. PubMed ID: 16250891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Boosting anti-idiotype immune response with recombinant AAV enhances tumour protection induced by gene gun vaccination.
    Cesco-Gaspere M; Zentilin L; Giacca M; Burrone OR
    Scand J Immunol; 2008 Jul; 68(1):58-66. PubMed ID: 18482206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice.
    Ruffini PA; Os A; Dolcetti R; Tjønnfjord GE; Munthe LA; Bogen B
    J Transl Med; 2014 Jul; 12():207. PubMed ID: 25059102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Growth inhibition of myeloma cells by anti-idiotype antibodies in the absence of membrane-bound immunoglobulin.
    Moshitzky S; Kukulansky T; Haimovich J; Hollander N
    Immunol Cell Biol; 2008; 86(3):261-7. PubMed ID: 18195726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro.
    Maloney DG; Kaminski MS; Burowski D; Haimovich J; Levy R
    Hybridoma; 1985; 4(3):191-209. PubMed ID: 3899906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants.
    Starnes CO; Carroll WL; Campbell MJ; Houston LL; Apell G; Levy R
    J Immunol; 1988 Jul; 141(1):333-9. PubMed ID: 3132505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta).
    Raychaudhuri S; Saeki Y; Chen JJ; Iribe H; Fuji H; Kohler H
    J Immunol; 1987 Jul; 139(1):271-8. PubMed ID: 2953815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulatory effects of tumor-derived heat shock protein in DNA vaccination against nasopharyngeal carcinoma.
    Wang JJ; Luo C; Li YH; Li GC
    Int Immunopharmacol; 2011 Apr; 11(4):462-7. PubMed ID: 21220058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MUC1- and Survivin-based DNA Vaccine Combining Immunoadjuvants CpG and interleukin-2 in a Bicistronic Expression Plasmid Generates Specific Immune Responses and Antitumour Effects in a Murine Colorectal Carcinoma Model.
    Liu C; Xie Y; Sun B; Geng F; Zhang F; Guo Q; Wu H; Yu B; Wu J; Yu X; Kong W; Zhang H
    Scand J Immunol; 2018 Feb; 87(2):63-72. PubMed ID: 29193199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma.
    Bendandi M; Marillonnet S; Kandzia R; Thieme F; Nickstadt A; Herz S; Fröde R; Inogés S; Lòpez-Dìaz de Cerio A; Soria E; Villanueva H; Vancanneyt G; McCormick A; Tusé D; Lenz J; Butler-Ransohoff JE; Klimyuk V; Gleba Y
    Ann Oncol; 2010 Dec; 21(12):2420-2427. PubMed ID: 20494963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors.
    Kwak LW; Campbell MJ; Czerwinski DK; Hart S; Miller RA; Levy R
    N Engl J Med; 1992 Oct; 327(17):1209-15. PubMed ID: 1406793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo.
    Franki SN; Steward KK; Betting DJ; Kafi K; Yamada RE; Timmerman JM
    Blood; 2008 Feb; 111(3):1504-11. PubMed ID: 17993615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intramuscular electroporation of a P1A-encoding plasmid vaccine delays P815 mastocytoma growth.
    Vandermeulen G; Uyttenhove C; De Plaen E; Van den Eynde BJ; Préat V
    Bioelectrochemistry; 2014 Dec; 100():112-8. PubMed ID: 24342164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma.
    Weiner GJ; Kaminski MS
    J Immunol; 1989 Jan; 142(1):343-51. PubMed ID: 2783325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.